Nausea, vomiting, diarrhea, constipation, and abdominal pain can occur in up to 20-40% of individuals [10]
Preiss D, Dawed A, Welsh P et al (2017) Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes
The western regions, including Jakarta and Surabaya, dominate the market due to their high population density and better healthcare infrastructure
Strategic Implications If validated in prospective randomized trials, GLP-1 receptor agonists could: Represent an adjunctive strategy in obesity-associated asthma Expand the therapeutic footprint of GLP-1s beyond metabolic disease Influence treatment guidelines in high-BMI asthma populations Given the rapid adoption of GLP-1 therapies globally, further investigation into respiratory benefits could have significant clinical and commercial implications
Whether due to reaching health goals, side effects, or cost concerns, discontinuing the medication can bring questions and challenges
The data on human SN cells was extracted by adding the downloaded metadata from all cells to meta.data in SeuratObject 13
